2DAVIS RC, HOBBS FDR, LIP GYH, et al. ABC of heart failuer history and epidemiology [ J ]. BMJ 2000,320:39.
3ACC/AHA 2005 guideline Update for the diagnosis and management of chronic heart failure in the adult : a report of the American College of Cardiology/American Heart Association Task Force on Practice Gtuidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) [J]. J Am Coll Cardiol,2005 ,46(6) :81.
4GARG R,YUSUF S. Overview of randomized trials of angiontensin-con-verting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative group on ACE inhibitor trials [J]. JAMA, 1995, 273 ( 18 ) : 1450.
5PACKER M,COATS AJ,FOWLER MB,et al. Effect of carvedilol on survival in severe chronic heart failure [ J ]. N Engl J Med, 2001,344(22) :1651.
6POOLE-WILSON PA,SWEDBERG K,CLELAND JG,et al. Comparison of carvediol and metoprolol on clinical outcomes in patienst with chronic heart failure in the carvediol or metoprolol european trial(COMET) : randomised controlled trial [ J]. Lancet, 2003,362(9377 ) :7.
7KRUM H. Beat-blockers in chrinic heart failure:what have we 1- earned? What do we still need to know[ J]. Curr Opin Pharmaeol,2003,3 (2) : 168.
8PITT B, POOLE-WILSON PA, SEGAL R, et al. Effect of losartan compared with captopril on mortality in patienst with symptomatic heart failure : randomised trial - the Losartan heart failure survival study ELITE [ J ]. Lancet ,2000,355 (9215) : 1582.
9TASUTAMOTO T, WADA A, MAEDA K, et al. Plasma brain natriuretic peptde level as a biochemical marker of morbidity and mortality in patienst with asymptomatic or minimally symptomatic left ventficular dysfunction [ J]. Eur Heart J, 1999,20 ( 24 ) : 1799.
10WIEZOREK, WU AH, CHRISTENSEN R, et al. A rapid B - type na-triuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure:a muhicenter evaluvtion [ J ]. Am Hrart J,2002,144 : 834.
